Nifty

:

11504.95

Sensex

:

38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Login

Nifty
Sensex

:
:

11504.95
38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

74/99

BSE: 524396 | NSE: BIOFILCHEM

Watchlist

NSE BSE

54.90

18-Sep-2020

Open
High
Low
Previous Close

54.90
54.90
54.90
52.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

33222
18.24
54.90
4.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

87.63
63.50
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

89.14
N/A
5.79

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

29.38
31.60
19.81

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.13
-17.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-1.17
-4.04
-35.51

P:E (Median)

8 Years
5 Years
3 Years

17.25
18.12
19.17

P:BV (Average)

8 Years
5 Years
3 Years

1.93
1.93
1.93

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.11
12.17
12.77

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 2.30 1.59 44.65% 3.71 2.47 50.20% 12.75 14.29 -10.78% 11.63 2.14 443.46%
Expenses 2.59 1.37 89.05% 3.20 2.19 46.12% 12.49 13.91 -10.21% 10.74 1.94 453.61%
EBITDA -0.29 0.22 - 0.52 0.28 85.71% 0.26 0.39 -33.33% 0.89 0.20 345.00%
EBIDTM -12.78% 13.99% 13.97% 11.36% 2.06% 2.70% 7.61% 9.13%
Other Income 0.64 0.01 6,300.00% 0.04 0.04 0.00% 0.09 0.02 350.00% 0.03 0.02 50.00%
Interest 0.03 0.04 -25.00% 0.03 0.04 -25.00% 0.03 0.04 -25.00% 0.03 0.04 -25.00%
Depreciation 0.10 0.09 11.11% 0.13 0.14 -7.14% 0.10 0.07 42.86% 0.10 0.07 42.86%
PBT 0.22 0.11 100.00% 0.40 0.14 185.71% 0.23 0.29 -20.69% 0.79 0.11 618.18%
Tax 0.00 0.00 0 0.26 0.12 116.67% 0.00 0.00 0 0.00 0.00 0
PAT 0.22 0.11 100.00% 0.15 0.02 650.00% 0.23 0.29 -20.69% 0.79 0.11 618.18%
PATM 9.34% 6.71% 3.96% 0.81% 1.79% 2.05% 6.79% 4.92%
EPS 0.13 0.07 85.71% 0.09 0.01 800.00% 0.14 0.18 -22.22% 0.48 0.06 700.00%

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 30.39 23.13 12.36 13.45 13.17 5.86 7.17 6.01 6.27 2.15 1.76 Net Sales Growth 48.32% 87.14% -8.10% 2.13% 124.74% -18.27% 19.30% -4.15% 191.63% 22.16% Cost Of Goods Sold 26.60 19.99 9.77 8.51 10.53 3.85 4.73 3.71 4.89 1.96 1.72 Gross Profit 3.79 3.14 2.59 4.94 2.65 2.01 2.44 2.30 1.38 0.19 0.03 GP Margin 12.47% 13.58% 20.95% 36.73% 20.12% 34.30% 34.03% 38.27% 22.01% 8.84% 1.70% Total Expenditure 29.02 22.10 11.42 10.83 12.30 5.13 6.21 5.00 5.88 3.26 2.50 Power & Fuel Cost - 0.37 0.33 0.44 0.37 0.35 0.28 0.37 0.23 0.08 0.04 % Of Sales - 1.60% 2.67% 3.27% 2.81% 5.97% 3.91% 6.16% 3.67% 3.72% 2.27% Employee Cost - 0.89 0.73 0.53 0.48 0.50 0.41 0.43 0.40 0.18 0.13 % Of Sales - 3.85% 5.91% 3.94% 3.64% 8.53% 5.72% 7.15% 6.38% 8.37% 7.39% Manufacturing Exp. - 0.20 0.14 0.47 0.49 0.19 0.27 0.20 0.13 0.52 0.11 % Of Sales - 0.86% 1.13% 3.49% 3.72% 3.24% 3.77% 3.33% 2.07% 24.19% 6.25% General & Admin Exp. - 0.24 0.39 0.48 0.32 0.16 0.15 0.20 0.18 0.11 0.13 % Of Sales - 1.04% 3.16% 3.57% 2.43% 2.73% 2.09% 3.33% 2.87% 5.12% 7.39% Selling & Distn. Exp. - 0.39 0.04 0.31 0.06 0.00 0.29 0.01 0.00 0.00 0.00 % Of Sales - 1.69% 0.32% 2.30% 0.46% 0% 4.04% 0.17% 0% 0% 0% Miscellaneous Exp. - 0.02 0.02 0.09 0.05 0.08 0.07 0.07 0.05 0.40 0.00 % Of Sales - 0.09% 0.16% 0.67% 0.38% 1.37% 0.98% 1.16% 0.80% 18.60% 21.02% EBITDA 1.38 1.03 0.94 2.62 0.87 0.73 0.96 1.01 0.39 -1.11 -0.74 EBITDA Margin 4.54% 4.45% 7.61% 19.48% 6.61% 12.46% 13.39% 16.81% 6.22% -51.63% -42.05% Other Income 0.80 0.10 0.10 0.14 0.53 0.46 0.06 0.06 0.04 2.26 1.40 Interest 0.12 0.16 0.15 0.16 0.15 0.21 0.15 0.19 0.08 0.01 0.00 Depreciation 0.43 0.37 0.30 0.28 0.26 0.25 0.22 0.21 0.19 0.15 0.11 PBT 1.64 0.60 0.59 2.31 0.98 0.74 0.65 0.67 0.16 0.99 0.54 Tax 0.26 0.12 0.12 0.52 0.20 0.15 0.13 0.13 0.01 0.00 0.00 Tax Rate 15.85% 20.00% 20.34% 22.51% 20.41% 20.27% 20.00% 19.40% 6.25% 0.00% 0.00% PAT 1.39 0.48 0.47 1.79 0.78 0.59 0.52 0.54 0.15 0.99 0.54 PAT before Minority Interest 1.39 0.48 0.47 1.79 0.78 0.59 0.52 0.54 0.15 0.99 0.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.57% 2.08% 3.80% 13.31% 5.92% 10.07% 7.25% 8.99% 2.39% 46.05% 30.68% PAT Growth 162.26% 2.13% -73.74% 129.49% 32.20% 13.46% -3.70% 260.00% -84.85% 83.33% EPS 0.85 0.29 0.29 1.10 0.48 0.36 0.32 0.33 0.09 0.61 0.33

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 13.65 13.17 12.70 10.91 8.41 7.86 7.36 6.84 6.70 1.73 Share Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 10.56 Total Reserves -2.62 -3.11 -3.58 -5.37 -7.86 -8.41 -8.91 -9.44 -9.57 -8.83 Non-Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.23 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.23 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 10.56 10.99 9.14 13.23 5.34 6.74 6.13 7.27 3.68 4.29 Trade Payables 8.58 9.14 7.10 11.59 2.11 3.64 3.11 4.72 2.34 4.27 Other Current Liabilities 0.23 0.17 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Borrowings 1.64 1.56 1.43 1.37 2.98 2.87 2.79 2.49 1.30 0.00 Short Term Provisions 0.12 0.11 0.50 0.26 0.25 0.23 0.23 0.06 0.03 0.02 Total Liabilities 24.21 24.16 21.84 24.14 13.75 14.60 13.49 14.11 10.38 10.25 Net Block 10.29 9.25 9.16 8.98 9.06 9.17 9.17 9.10 8.49 7.66 Gross Block 11.24 9.83 9.45 11.04 10.85 10.68 10.44 10.14 9.32 8.32 Accumulated Depreciation 0.95 0.58 0.29 2.06 1.79 1.51 1.27 1.04 0.84 0.67 Non Current Assets 10.29 9.25 9.16 8.98 9.06 9.17 9.17 9.10 8.49 7.66 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 13.92 14.91 12.68 15.16 4.70 5.43 4.32 5.01 1.89 2.28 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1.19 1.02 0.17 0.10 0.17 0.27 0.32 0.22 0.06 0.00 Sundry Debtors 12.03 12.98 11.46 13.98 3.65 4.10 3.34 4.11 1.50 0.21 Cash & Bank 0.14 0.37 0.31 0.18 0.13 0.18 0.13 0.25 0.09 1.29 Other Current Assets 0.57 0.10 0.15 0.00 0.75 0.87 0.53 0.42 0.24 0.78 Short Term Loans & Adv. 0.44 0.43 0.59 0.89 0.75 0.87 0.53 0.42 0.24 0.78 Net Current Assets 3.36 3.92 3.53 1.93 -0.64 -1.31 -1.81 -2.26 -1.79 -2.01 Total Assets 24.21 24.16 21.84 24.14 13.76 14.60 13.49 14.11 10.38 10.26

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 1.26 0.46 0.71 0.14 0.01 0.21 -0.13 -0.21 -1.25 2.77 PBT 0.60 0.59 2.31 0.98 0.74 0.65 0.67 0.15 0.99 0.54 Adjustment 0.53 0.45 0.45 0.42 0.46 0.37 0.40 0.27 0.49 0.42 Changes in Working Capital 0.25 -0.07 -1.84 -0.96 -0.84 -0.52 -1.00 -0.55 -2.73 1.81 Cash after chg. in Working capital 1.37 0.97 0.91 0.44 0.35 0.50 0.07 -0.13 -1.24 2.78 Interest Paid 0.00 0.00 0.00 -0.15 -0.21 -0.15 -0.19 -0.08 -0.01 0.00 Tax Paid -0.11 -0.50 -0.20 -0.15 -0.13 -0.14 -0.01 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.41 -0.38 -0.48 -0.19 -0.17 -0.24 -0.30 -0.82 -1.00 -0.63 Net Fixed Assets -1.41 -0.38 1.59 -0.19 -0.17 -0.24 -0.30 -0.82 -1.00 -0.62 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 0.00 -2.07 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 Cash from Financing Activity -0.08 -0.02 -0.11 0.10 0.11 0.08 0.31 1.19 1.05 -0.91 Net Cash Inflow / Outflow -0.24 0.06 0.13 0.05 -0.05 0.05 -0.12 0.16 -1.20 1.24 Opening Cash & Equivalents 0.37 0.31 0.18 0.13 0.18 0.13 0.25 0.09 1.29 0.05 Closing Cash & Equivalent 0.14 0.37 0.31 0.18 0.13 0.18 0.13 0.25 0.09 1.29

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 8.39 8.09 7.80 4.39 2.85 2.51 2.19 1.85 1.76 -2.31 ROA 1.99% 2.05% 7.81% 4.13% 4.14% 3.68% 3.93% 1.23% 9.61% 5.84% ROE 3.60% 3.64% 18.09% 13.28% 13.47% 13.53% 16.49% 5.12% 462.75% 0.00% ROCE 5.06% 5.13% 21.86% 14.04% 12.97% 12.09% 14.53% 5.05% 33.57% 30.11% Fixed Asset Turnover 2.19 1.28 1.31 1.20 0.54 0.68 0.58 0.64 0.24 0.22 Receivable days 197.31 360.94 345.20 244.36 241.46 189.36 226.24 163.34 145.17 64.21 Inventory Days 17.48 17.59 3.56 3.64 13.70 15.17 16.41 8.18 5.46 11.75 Payable days 146.68 239.24 317.92 205.27 204.15 204.37 274.80 220.37 413.46 545.10 Cash Conversion Cycle 68.12 139.29 30.84 42.72 51.02 0.15 -32.15 -48.85 -262.83 -469.14 Total Debt/Equity 0.12 0.12 0.11 0.19 0.64 0.70 0.78 0.82 0.45 -1.74 Interest Cover 4.70 4.86 15.12 7.46 4.51 5.24 4.50 2.94 109.70 167.68

Top Investors:

starline equifin private limited

libra healthcare private limited

ksl and industries limited

hiren vasantlal shah

kishor himmatsinh jhala

gom industries ltd

Annual Reports:

News Update:

Biofil Chem & Pharma - Quarterly Results
25th Aug 2020, 17:10 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback